EXPERIENCES WITH NEW ANTIRHEUMATIC DRUG IN PRACTICE

被引:0
作者
ZIEGELMAYER, W [1 ]
机构
[1] FACHARZT INNERE KRANKHEITEN, FRIEDRICH EBERT ANLAGE 39, 6 FRANKFURT MAIN, WEST GERMANY
来源
MEDIZINISCHE WELT | 1974年 / 25卷 / 10期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:426 / 428
页数:3
相关论文
共 50 条
[21]   Antirheumatic drug toxicity in children [J].
不详 .
HOSPITAL MEDICINE, 1999, 60 (01) :69-69
[22]   AN IMMUNOPHARMACOLOGICAL PROFILE OF LOBENZARIT DISODIUM (CCA), A NEW IMMUNOMODULATING ANTIRHEUMATIC DRUG [J].
OHSUGI, Y ;
NAKANO, T ;
UENO, K ;
FUKUI, H ;
NIKI, R ;
SUGAWARA, Y ;
HATA, S .
INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, 1985, 1 (02) :85-92
[23]   EFFECTS OF BUCILLAMINE, A NEW ANTIRHEUMATIC DRUG, ON THE EXPERIMENTAL AUTOIMMUNE UVEITIS IN RATS [J].
SAWA, K ;
MOCHIZUKI, M .
EXPERIMENTAL EYE RESEARCH, 1994, 58 (04) :431-438
[24]   MODULATION OF ACUTE PHASE PROTEINS BY TENIDAP, A NEW ANTIINFLAMMATORY, ANTIRHEUMATIC DRUG [J].
LOOSE, LD ;
LITTMAN, BH ;
SIPE, JD .
CLINICAL RESEARCH, 1990, 38 (02) :A579-A579
[25]   IMMUNOMODULATING EFFECTS OF THE NEW ANTIRHEUMATIC DRUG TENIDAP ON COLLAGEN-INDUCED [J].
MATSUSHITA, I ;
MATSUNO, H ;
KADOWAKI, KM ;
OKADA, C ;
TSUJI, H .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1995, 17 (03) :213-219
[26]   NAPROXEN, A SPECIFIC ANTIRHEUMATIC DRUG [J].
ALTMANN, H ;
KLEIN, G ;
WOTTAWA, A .
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1975, 25 (NA2) :293-293
[27]   Drug-drug interactions in antirheumatic treatment [J].
Krueger, K. .
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2012, 71 (03) :209-215
[28]   Validation of New Antirheumatic Drug Use as a Proxy for Increased JIA Disease Activity [J].
Gabbeta, Avinash ;
Mulvihill, Evan ;
Beukelman, Timothy ;
Lewis, James ;
Rose, Carlos ;
Strom, Brian ;
Horton, Daniel .
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[30]   DRUG-DRUG INTERACTION WITH THE USE OF ANTIRHEUMATIC DRUGS [J].
ARNESON, HT ;
COLTON, RS .
MINNESOTA MEDICINE, 1987, 70 (10) :589-&